72: Should We All Switch To Bivalirudin?

ED ECMO by Zack Shinar, MD

Mar 25, 202129:39Science & Medicine

Heparin has been the mainstay of anticoagulation for ECMO patients for years. In recent years, this has been challenged. Bivalirudin has b ecome a potential better anticoagulant. Troy Seelhammer in EDECMO episode 55 gave...

Related Episodes

Continue listening to more episodes from ED ECMO.

75: Pulmonary Embolism and ECPR

Dec 3, 2021 - 8:10

In this short episode, Zack makes two points. One, it was tough to get to where we are with ECMO acceptan...

74: Do 70 year old’s deserve ECPR? A Deep Dive into the Economics of ECPR

Oct 14, 2021 - 28:22

Have you ever pondered whether all the work over ECPR was worth it? Even if you did save a few patients,...

73b: Conclusions for Hyperinvasive Trial with Jan Belohlavek

May 24, 2021 - 5:09

Here is the conclusion for the interview of Jan Belohlavek and his Hyperinvasive Trial

73:The Hyperinvasive Trial with Jan Belohlavek

May 24, 2021 - 53:39

Wait...ECPR works? To the believers, this has been a foregone conclusion. To the rest of the world, the q...

71: Should We Prioritize VV-ECMO over ECPR?

Feb 24, 2021 - 37:55

In this episode, we dive into the abyss of resource allocation. Much of the world is saying that the limi...

70: REBOA REDUX – Management of Hemorrhagic Shock in Non-Trauma Patients – with Bellezzo & Zaf Qasim

Jan 2, 2021 - 53:34

In this episode Joe Bellezzo talks with Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA)...

69: 2020 Synopsis

Dec 18, 2020 - 11:08

2020 was a crazy year. This month Zack goes through the biggest ECMO lessons learned in 2020. This is a s...

68: ARREST – The First Randomized ECPR Trial Ever

Nov 22, 2020 - 47:24

The ARREST Trial is published! Demetris Yannopoulos, Jason Bartos and their army of rockstars have done i...